Boston Scientific NIR Stent With SOX Inventory Sufficient For Relaunch
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific has sufficient inventory of its modified NIR coronary stent with the SOX delivery system to support relaunch the week of March 20, the firm reported March 16 in announcing FDA approval of a premarket approval application supplement. Product manufacturing and shipments to Japan commenced earlier this year following approval by the Japanese Ministry of Health in December.